FI821316L - Foerfarande foer framstaellning av nya substituerade imidazol- och imidazolinderivat - Google Patents

Foerfarande foer framstaellning av nya substituerade imidazol- och imidazolinderivat

Info

Publication number
FI821316L
FI821316L FI821316A FI821316A FI821316L FI 821316 L FI821316 L FI 821316L FI 821316 A FI821316 A FI 821316A FI 821316 A FI821316 A FI 821316A FI 821316 L FI821316 L FI 821316L
Authority
FI
Finland
Prior art keywords
imports
immediate
framework
immediate imports
Prior art date
Application number
FI821316A
Other languages
English (en)
Other versions
FI821316A0 (fi
Inventor
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of FI821316A0 publication Critical patent/FI821316A0/fi
Publication of FI821316L publication Critical patent/FI821316L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI821316A 1981-04-22 1982-04-15 Foerfarande foer framstaellning av nya substituerade imidazol- och imidazolinderivat FI821316L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8112506A GB2096987B (en) 1981-04-22 1981-04-22 Substituted imidazole and imidazole derivatives and their preparation and use

Publications (2)

Publication Number Publication Date
FI821316A0 FI821316A0 (fi) 1982-04-15
FI821316L true FI821316L (fi) 1982-10-23

Family

ID=10521291

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821316A FI821316L (fi) 1981-04-22 1982-04-15 Foerfarande foer framstaellning av nya substituerade imidazol- och imidazolinderivat

Country Status (10)

Country Link
EP (1) EP0064820A1 (fi)
JP (1) JPS57181063A (fi)
AU (1) AU8223082A (fi)
CA (1) CA1183544A (fi)
DD (1) DD207375A1 (fi)
DK (1) DK174782A (fi)
FI (1) FI821316L (fi)
GB (1) GB2096987B (fi)
NO (1) NO821288L (fi)
ZA (1) ZA822346B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
US4992459A (en) * 1983-04-12 1991-02-12 Smithkline Beecham Corporation Dopamine-β-hydroxylase inhibitors
DE3428342A1 (de) * 1984-08-01 1986-02-13 Boehringer Ingelheim Vetmedica GmbH, 6507 Ingelheim Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4719223A (en) * 1985-10-31 1988-01-12 Smithkline Beckman Corporation Imidazolethiol dopamine-beta-hydroxylase inhibitors
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
US4876266A (en) * 1987-12-31 1989-10-24 Smithkline Beckman Corporation 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors
DE68917897D1 (de) * 1988-12-15 1994-10-06 Texaco Development Corp Verfahren zur Herstellung von Imidazolen.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050520A (en) * 1960-03-31 1962-08-21 Air Prod & Chem Process of preparing 2-olefinic imidazoles
US3502661A (en) * 1967-02-14 1970-03-24 Pfizer & Co C Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
IL39413A0 (en) * 1971-05-13 1972-07-26 Sparamedica Ag Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
JPS51143668A (en) * 1975-05-30 1976-12-10 Scherico Ltd Production of novel 22 imidazoline compound

Also Published As

Publication number Publication date
GB2096987B (en) 1984-04-04
NO821288L (no) 1982-10-25
CA1183544A (en) 1985-03-05
GB2096987A (en) 1982-10-27
JPS57181063A (en) 1982-11-08
AU8223082A (en) 1982-10-28
DD207375A1 (de) 1984-02-29
ZA822346B (en) 1983-03-30
EP0064820A1 (en) 1982-11-17
FI821316A0 (fi) 1982-04-15
DK174782A (da) 1982-10-23

Similar Documents

Publication Publication Date Title
FI823787A0 (fi) Foerfarande foer framstaellning av nya substituerade benzimidazoler
FI822511L (fi) Nya bicykliska pyrimidin-5-on-derivat
FI823556L (fi) Foerfarande foer framstaellning av hydroxipropylstaerkelse
FI813279L (fi) Foerfarande foer framstaellning av azabicyklo-oktan-karbolxylsyror
FI822747A0 (fi) Foerfarande foer framstaellning av pyridazinaminfoereningar
FI822857A0 (fi) Foerfarande och anordning foer framstaellning av en faergkilfolie
FI832033L (fi) Anordning foer upparbetning av traed eller dylikt
FI803547L (fi) Foerfaranden foer framstaellning av nya piperidylbensimidazolinoner
FI821833A0 (fi) Foerfarande foer framstaellning av nya antracykliner
FI822785A0 (fi) Nya imidazokinazolinderivat
FI821316A0 (fi) Foerfarande foer framstaellning av nya substituerade imidazol- och imidazolinderivat
FI821305L (fi) Foerfarande foer framstaellning av nya alifatiska fenylkarboxylsyraderivat
FI823671A0 (fi) Anordning foer framstaellning av en kontinuerlig wellpappsbana
FI823156L (fi) Foerfarande foer framstaellning av nya polycykliska polyazaheterocykler
FI832508A0 (fi) Foerfarande foer framstaellning av maennisko-gamma-interferon
FI784017A (fi) Foerfarande foer framstaellning av nya arylaminoimidazolinderivater
FI791350A (fi) Foerfarande foer framstaellning av nya derivat piperazin-metanimin
FI822215L (fi) Foerfarande foer framstaellning av nya benzoyl-fenyl-piperdinderivat
FI814067L (fi) Foerfarande foer framstaellning av nya laktamfoereningar
FI823921A0 (fi) Foerfarande foer framstaellning av parakinon- eller ortokinonderivat
FI811638A0 (fi) Foerfarande foer framstaellning av en terapeutiskt vaerdefull heterocyklisk foerening
FI821573L (fi) Foerfarande foer framstaellning av nya substituerade 2-aminoetanoler
FI792011A (fi) Foerfarande foer framstaellning av nya oxatiafoereningar
FI823877A0 (fi) Foerfarande foer framstaellning av braensle av fast bitumen- och/eller lignosellulosamaterial
FI833873A0 (fi) Foerfarande foer framstaellning av n-fosfonometylglycin

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FARMOS-YHTYMAE OY